Product How it works Pricing Blog FAQ About Contact
United States

Silgan (NYSE: SLGN) stock: the official figures

Silgan (SILGAN HOLDINGS INC) is listed on the New York Stock Exchange under the ticker SLGN and belongs to the consumer discretionary sector. In fiscal 2025 it reported revenue of $6,483m and a net profit of $288.4m, according to the annual accounts it filed with the regulator.

Identifiers for Silgan: SEC CIK 849869.

Fiscal 2025 figures

Consolidated annual accounts of Silgan, in millions of US dollars
Item20252024Change
Revenue$6,483m$5,855m+10.7%
Operating profit$597.9m$514.0m+16.3%
Net profit$288.4m$276.4m+4.4%
Earnings per share$2.71$2.59+4.6%
Operating margin9.2%8.8%+0.4 pts
Net margin4.4%4.7%−0.3 pts
Total assets$9,397m$8,585m+9.5%
Equity$2,274m$1,990m+14.3%
Cash$1,081m$822.9m+31.3%
Operating cash flow$729.8m$721.9m+1.1%

Margins are calculated from the filed figures: operating profit and net profit over revenue.

10 fiscal years

Revenue, in millions of US dollars3,61320164,09020174,44920184,49020194,92220205,67720216,41120225,98820235,85520246,4832025Net profit, in millions of US dollars153.42016269.72017224.02018193.82019308.72020359.12021340.82022326.02023276.42024288.42025
Fiscal yearRevenueOperating profitNet profitEarnings per shareDocument
2025$6,483m$597.9m$288.4m$2.71Annual report
2024$5,855m$514.0m$276.4m$2.59Annual report
2023$5,988m$595.4m$326.0m$3.00Annual report
2022$6,411m$600.5m$340.8m$3.09Annual report
2021$5,677m$574.7m$359.1m$3.25Annual report
2020$4,922m$510.9m$308.7m$2.79Annual report
2019$4,490m$359.5m$193.8m$1.75Annual report
2018$4,449m$412.1m$224.0m$2.03Annual report
2017$4,090m$357.0m$269.7m$2.44Annual report
2016$3,613m$299.7m$153.4m$2.56Annual report

The full income statement, balance sheet and cash flow statement are in the annual accounts of Silgan. Year by year: dividends paid. Purchases and sales by its executives and directors are in insider transactions.

Dividends

In fiscal 2025, Silgan paid $85.8m in dividends, 29.7% of its net profit, according to its cash flow statement.

Dividends paid by Silgan in each fiscal year, in millions of US dollars
Fiscal yearDividends paidShare of net profit
2025$85.8m29.7%
2024$82.1m29.7%
2023$78.9m24.2%
2022$71.9m21.1%
2021$62.5m17.4%
2020$53.6m17.4%
2019$50.8m26.2%
2018$44.5m19.9%
2017$40.5m15.0%
2016$40.9m26.7%

Cash paid out as dividends during the fiscal year, including dividends to minority shareholders of subsidiaries when the company does not report them separately. It is not the dividend per share.

Members of Congress who traded Silgan

In the congressional reports read up to 9 November 2026, 2 members have disclosed 3 transactions in Silgan: Gilbert Ray Cisneros, Jr. (2), Josh Gottheimer (1).

Frequently asked questions about Silgan

How much did Silgan earn in fiscal 2025?
Silgan reported a net profit of $288.4m for fiscal 2025, on revenue of $6,483m. The year before it reported a net profit of $276.4m.
Does Silgan pay a dividend?
In fiscal 2025, Silgan paid $85.8m in dividends, 29.7% of its net profit, according to its cash flow statement.
What are the earnings per share of Silgan?
They were $2.71 in fiscal 2025, compared with $2.59 the year before.
Where is Silgan listed?
Silgan is listed on the New York Stock Exchange under the ticker SLGN and belongs to the consumer discretionary sector.
Where do the figures for Silgan come from?
From the annual report (Form 10-K) that Silgan files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

The annual accounts come from the annual report (Form 10-K) that Silgan files with the SEC, the US securities regulator. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.

Dividend per share of Silgan by fiscal year, with the filing behind every figure: Silgan dividend history.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.